EMA and the European Organisation of Research and Treatment of Oncology (EORTC) are organising a follow-up multi-stakeholder workshop on soft tissue and bone sarcoma on 24th May 2024.
This follows the workshop which was held on 12th January and addressed the question on how we can develop new treatments in ultra-rare sarcomas, as a model for ultra-rare tumours.
This multi-stakeholder workshop will bring together academia, learned societies, patients and medicines regulators.
The aims of the workshop are to discuss a framework for developing medicines for ultra rare indication.